TMC435 in Patients Infected with HCV Genotype 1 Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Virologic Analyses of The ASPIRE Trial

被引：0
|
作者：
Picchio, Gaston
Lenz, Oliver
Fevery, Bart
Vijgen, Leen
Verbeeck, Jannick
Peeters, Monika
Beumont-Mauviel, Maria
Zeuzem, Stefan
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [21] TMC435 IN COMBINATION WITH PEGINTERFERON AND RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1 PATIENTS: FINAL ANALYSIS OF THE PILLAR PHASE IIB STUDY
    Fried, Michael
    Buti, Maria
    Dore, Gregory J.
    Flisiak, Robert
    Ferenci, Peter
    Jacobson, Ira M.
    Marcellin, Patrick
    Manns, Michael P.
    Nikitin, Igor
    Poordad, F. Fred
    Sherman, Morris
    Zeuzem, Stefan
    Lenz, Oliver
    Peeters, Monika
    Sekar, Vanitha
    De Smedt, Goedele
    HEPATOLOGY, 2011, 54 : 1429A - 1429A
  • [22] Simeprevir (TMC435) with peg-interferon α-2a/ribavirin for treatment of chronic HCV genotype 1 infection in patients who relapsed after previous interferon-based therapy: efficacy and safety in patient sub-populations in the PROMISE phase III trial
    Forns, Xavier
    Lawitz, Eric
    Zeuzem, Stefan
    Gane, Edward J.
    Bronowicki, Jean-Pierre
    Andreone, Pietro
    Horban, Andrzej
    Brown, Ashley S.
    Peeters, Monika
    Lenz, Oliver
    Ouwerkerk-Mahadevan, Sivi
    Scott, Jane A.
    Kalmeijer, Ronald
    De La Rosa, Guy
    Sinha, Rekha
    Beumont-Mauviel, Maria
    HEPATOLOGY, 2013, 58 : 737A - 738A
  • [23] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Imanaka, Kazuho
    Yamada, Akira
    Oshita, Masahide
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Nagase, Toshihiko
    Inui, Yoshiaki
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Hayashi, Eijiro
    Imai, Yasuharu
    Kato, Michio
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Ishida, Hisashi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (07) : 944 - 952
  • [24] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
    Tsugiko Oze
    Naoki Hiramatsu
    Takayuki Yakushijin
    Kiyoshi Mochizuki
    Kazuho Imanaka
    Akira Yamada
    Masahide Oshita
    Akira Kaneko
    Hideki Hagiwara
    Eiji Mita
    Toshifumi Ito
    Toshihiko Nagase
    Yoshiaki Inui
    Taizo Hijioka
    Shinji Tamura
    Harumasa Yoshihara
    Eijiro Hayashi
    Yasuharu Imai
    Michio Kato
    Atsushi Hosui
    Takuya Miyagi
    Yuichi Yoshida
    Hisashi Ishida
    Tomohide Tatsumi
    Shinichi Kiso
    Tatsuya Kanto
    Akinori Kasahara
    Tetsuo Takehara
    Norio Hayashi
    Journal of Gastroenterology, 2011, 46 : 944 - 952
  • [25] ANTIVIRAL ACTIVITY AND SAFETY OF TMC435 COMBINED WITH PEGINTERFERON ALPHA-2A AND RIBAVIRIN IN PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION WHO FAILED PREVIOUS IFN-BASED THERAPY
    Marcellin, P.
    Reesink, H.
    Berg, T.
    Cramp, M.
    Flisiak, R.
    Van Vlierberghe, H.
    Verloes, R.
    Lenz, O.
    Peeters, M.
    Sekar, V.
    De Smedt, G.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S385 - S385
  • [26] OPERA-1 TRIAL: INTERIM ANALYSIS OF SAFETY AND ANTIVIRAL ACTIVITY OF TMC435 IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS
    Manns, M.
    Reesink, H.
    Moreno, C.
    Berg, T.
    Benhamou, Y.
    Horsmans, Y.
    Dusheiko, G.
    Flisiak, R.
    Meyvisch, P.
    Lenz, O.
    Sekar, V.
    van't Klooster, G.
    Simmen, K.
    Verloes, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S7 - S7
  • [27] SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAIVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL
    Jacobson, I.
    Dore, G. J.
    Foster, G. R.
    Fried, M. W.
    Radu, M.
    Rafalskiy, V. V.
    Moroz, L.
    Craxi, A.
    Peeters, M.
    Lenz, O.
    Ouwerkerk-Mahadevan, S.
    Kalmeijer, R.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S574 - S574
  • [28] Treatment with pegylated interferon alpha 2B and ribavirin produces significant sustained virologic response rates in HCV infected patients who failed prior therapy
    Gaglio, PJ
    Brown, M
    Zimmerman, D
    Choi, J
    Heiler, L
    Brown, R
    GASTROENTEROLOGY, 2003, 124 (04) : A767 - A767
  • [29] Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
    Baek, Yang Hyun
    Lee, Sung Wook
    Yoo, Hyun Seung
    Yoon, Hyun Ah
    Kim, Ja Won
    Kim, Young Hoon
    Kim, Ha Youn
    Han, Sang Young
    GUT AND LIVER, 2007, 1 (01) : 87 - 89
  • [30] Simeprevir (TMC435) With Peginterferon/Ribavirin for Treatment of Chronic HCV Genotype-1 Infection in Treatment-Naive Patients: Results From QUEST-2, a Phase III Trial
    Poordad, Fred
    Manns, Michael P.
    Marcellin, Patrick
    de Araujo, Evaldo Stanislau Affonso
    Buti, Maria
    Horsmans, Yves
    Janczewska, Ewa
    Villamil, Federico
    Peeters, Monika
    Lenz, Oliver
    Ouwerkerk-Mahadevan, Sivi
    Kalmeijer, Ronald
    Beumont-Mauviel, Maria
    GASTROENTEROLOGY, 2013, 144 (05) : S151 - S151
12345